Literature DB >> 28315139

Medicines Save, Medicines Kill.

Joel Lexchin1,2,3.   

Abstract

Mesh：

Year:  2017        PMID： 28315139     DOI： 10.1007/s40264-017-0521-6

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  12 in total

1.  The FDA and new safety warnings.

Authors:  Thomas J Moore; Sonal Singh; Curt D Furberg
Journal:  Arch Intern Med       Date:  2012-01-09

2.  The Food and Drug Administration Amendments Act and postmarketing commitments.

Authors:  Kevin Fain; Matthew Daubresse; G Caleb Alexander
Journal:  JAMA       Date:  2013-07-10       Impact factor: 56.272

3.  Drug-review deadlines and safety problems.

Authors:  Daniel Carpenter; Evan James Zucker; Jerry Avorn
Journal:  N Engl J Med       Date:  2008-03-27       Impact factor: 91.245

4.  Mediator scandal rocks French medical community.

Authors:  Asher Mullard
Journal:  Lancet       Date:  2011-03-12       Impact factor: 79.321

5.  New "21st Century Cures" Legislation: Speed and Ease vs Science.

Authors:  Aaron S Kesselheim; Jerry Avorn
Journal:  JAMA       Date:  2017-02-14       Impact factor: 56.272

6.  Comparisons of Food and Drug Administration and European Medicines Agency risk management implementation for recent pharmaceutical approvals: report of the International Society for Pharmacoeconomics and outcomes research risk benefit management working group.

Authors:  Yvonne Lis; Melissa H Roberts; Shital Kamble; Jeff J Guo; Dennis W Raisch
Journal:  Value Health       Date:  2012-11-03       Impact factor: 5.725

7.  New drugs and safety: what happened to new active substances approved in Canada between 1995 and 2010?

Authors:  Joel Lexchin
Journal:  Arch Intern Med       Date:  2012-11-26

8.  "Adaptive pathways" to drug authorisation: adapting to industry?

Authors:  Courtney Davis; Joel Lexchin; Tom Jefferson; Peter Gøtzsche; Martin McKee
Journal:  BMJ       Date:  2016-08-16

Review 9.  Industry sponsorship and research outcome.

Authors:  Andreas Lundh; Joel Lexchin; Barbara Mintzes; Jeppe B Schroll; Lisa Bero
Journal:  Cochrane Database Syst Rev       Date:  2017-02-16

10.  How safe are new drugs? Market withdrawal of drugs approved in Canada between 1990 and 2009.

Authors:  Joel Lexchin
Journal:  Open Med       Date:  2014-01-28
View more
  1 in total

Review 1.  The concept of justifiable healthcare and how big data can help us to achieve it.

Authors:  Wim van Biesen; Catherine Van Der Straeten; Sigrid Sterckx; Johan Steen; Lisa Diependaele; Johan Decruyenaere
Journal:  BMC Med Inform Decis Mak       Date:  2021-03-06       Impact factor: 2.796
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.